422 related articles for article (PubMed ID: 20935658)
1. Orally delivered thioketal nanoparticles loaded with TNF-α-siRNA target inflammation and inhibit gene expression in the intestines.
Wilson DS; Dalmasso G; Wang L; Sitaraman SV; Merlin D; Murthy N
Nat Mater; 2010 Nov; 9(11):923-8. PubMed ID: 20935658
[TBL] [Abstract][Full Text] [Related]
2. Orally targeted galactosylated chitosan poly(lactic-co-glycolic acid) nanoparticles loaded with TNF-ɑ siRNA provide a novel strategy for the experimental treatment of ulcerative colitis.
Huang Y; Guo J; Gui S
Eur J Pharm Sci; 2018 Dec; 125():232-243. PubMed ID: 30315858
[TBL] [Abstract][Full Text] [Related]
3. TNFα gene silencing mediated by orally targeted nanoparticles combined with interleukin-22 for synergistic combination therapy of ulcerative colitis.
Xiao B; Chen Q; Zhang Z; Wang L; Kang Y; Denning T; Merlin D
J Control Release; 2018 Oct; 287():235-246. PubMed ID: 30107214
[TBL] [Abstract][Full Text] [Related]
4. Effects of particle size and binding affinity for small interfering RNA on the cellular processing, intestinal permeation and anti-inflammatory efficacy of polymeric nanoparticles.
Cheng W; Tang C; Yin C
J Gene Med; 2015; 17(10-12):244-56. PubMed ID: 26418829
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticles with surface antibody against CD98 and carrying CD98 small interfering RNA reduce colitis in mice.
Xiao B; Laroui H; Viennois E; Ayyadurai S; Charania MA; Zhang Y; Zhang Z; Baker MT; Zhang B; Gewirtz AT; Merlin D
Gastroenterology; 2014 May; 146(5):1289-300.e1-19. PubMed ID: 24503126
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound-Mediated Delivery of RNA to Colonic Mucosa of Live Mice.
Schoellhammer CM; Lauwers GY; Goettel JA; Oberli MA; Cleveland C; Park JY; Minahan D; Chen Y; Anderson DG; Jaklenec A; Snapper SB; Langer R; Traverso G
Gastroenterology; 2017 Apr; 152(5):1151-1160. PubMed ID: 28088460
[TBL] [Abstract][Full Text] [Related]
7. siRNA release kinetics from polymeric nanoparticles correlate with RNAi efficiency and inflammation therapy via oral delivery.
He C; Yue H; Xu L; Liu Y; Song Y; Tang C; Yin C
Acta Biomater; 2020 Feb; 103():213-222. PubMed ID: 31812844
[TBL] [Abstract][Full Text] [Related]
8. Fab'-bearing siRNA TNFα-loaded nanoparticles targeted to colonic macrophages offer an effective therapy for experimental colitis.
Laroui H; Viennois E; Xiao B; Canup BS; Geem D; Denning TL; Merlin D
J Control Release; 2014 Jul; 186():41-53. PubMed ID: 24810114
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional polymeric nanoparticles for oral delivery of TNF-α siRNA to macrophages.
He C; Yin L; Tang C; Yin C
Biomaterials; 2013 Apr; 34(11):2843-54. PubMed ID: 23347838
[TBL] [Abstract][Full Text] [Related]
10. Optimization of multifunctional chitosan-siRNA nanoparticles for oral delivery applications, targeting TNF-α silencing in rats.
He C; Yin L; Song Y; Tang C; Yin C
Acta Biomater; 2015 Apr; 17():98-106. PubMed ID: 25662912
[TBL] [Abstract][Full Text] [Related]
11. Lipidoid-polymer hybrid nanoparticles loaded with TNF siRNA suppress inflammation after intra-articular administration in a murine experimental arthritis model.
Jansen MAA; Klausen LH; Thanki K; Lyngsø J; Skov Pedersen J; Franzyk H; Nielsen HM; van Eden W; Dong M; Broere F; Foged C; Zeng X
Eur J Pharm Biopharm; 2019 Sep; 142():38-48. PubMed ID: 31199978
[TBL] [Abstract][Full Text] [Related]
12. Colonic gene silencing using siRNA-loaded calcium phosphate/PLGA nanoparticles ameliorates intestinal inflammation in vivo.
Frede A; Neuhaus B; Klopfleisch R; Walker C; Buer J; Müller W; Epple M; Westendorf AM
J Control Release; 2016 Jan; 222():86-96. PubMed ID: 26699423
[TBL] [Abstract][Full Text] [Related]
13. Oral administration of ginger-derived nanolipids loaded with siRNA as a novel approach for efficient siRNA drug delivery to treat ulcerative colitis.
Zhang M; Wang X; Han MK; Collins JF; Merlin D
Nanomedicine (Lond); 2017 Aug; 12(16):1927-1943. PubMed ID: 28665164
[TBL] [Abstract][Full Text] [Related]
14. Zn-dipicolylamine-based reactive oxygen species-responsive lipids for siRNA delivery and in vivo colitis treatment.
Guo Y; He X; Zhao RM; Yang HZ; Huang Z; Zhang J; Yu XQ
Acta Biomater; 2022 Jul; 147():287-298. PubMed ID: 35489607
[TBL] [Abstract][Full Text] [Related]
15. Trimethyl chitosan-cysteine nanoparticles for systemic delivery of TNF-α siRNA via oral and intraperitoneal routes.
He C; Yin L; Tang C; Yin C
Pharm Res; 2013 Oct; 30(10):2596-606. PubMed ID: 23715740
[TBL] [Abstract][Full Text] [Related]
16. Oral delivery of siRNA lipid nanoparticles: Fate in the GI tract.
Ball RL; Bajaj P; Whitehead KA
Sci Rep; 2018 Feb; 8(1):2178. PubMed ID: 29391566
[TBL] [Abstract][Full Text] [Related]
17. Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation.
Aouadi M; Tesz GJ; Nicoloro SM; Wang M; Chouinard M; Soto E; Ostroff GR; Czech MP
Nature; 2009 Apr; 458(7242):1180-4. PubMed ID: 19407801
[TBL] [Abstract][Full Text] [Related]
18. Oral delivery of anti-TNF antibody shielded by natural polyphenol-mediated supramolecular assembly for inflammatory bowel disease therapy.
Wang X; Yan J; Wang L; Pan D; Xu Y; Wang F; Sheng J; Li X; Yang M
Theranostics; 2020; 10(23):10808-10822. PubMed ID: 32929381
[No Abstract] [Full Text] [Related]
19. Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation.
Xiao B; Zhang Z; Viennois E; Kang Y; Zhang M; Han MK; Chen J; Merlin D
Theranostics; 2016; 6(12):2250-2266. PubMed ID: 27924161
[TBL] [Abstract][Full Text] [Related]
20. Engineering of Solid Dosage Forms of siRNA-Loaded Lipidoid-Polymer Hybrid Nanoparticles Using a Quality-by-Design Approach.
Lokras A; Foged C; Thakur A
Methods Mol Biol; 2021; 2282():137-157. PubMed ID: 33928574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]